8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.

Core Insights - The company reported an 8% organic sales growth in the first nine months, with strong profitability and cash flow, achieving a 37.3% adjusted EBITDA margin despite currency challenges [1][4] - For the fourth quarter, the company anticipates mid-single-digit organic sales growth and has raised its full-year organic sales growth expectation to 7-8% [1][4] - The company continues to execute its strategic priorities effectively, aiming to meet its 2030 targets [1] Sales Performance - Organic sales growth was 8%, with a Q3 growth of 6%, impacted by exiting certain countries by approximately 1 percentage point [4] - Food & Health segment achieved 9% organic sales growth, while Planetary Health recorded 8% [4] - Emerging Markets saw a 12% organic sales growth, compared to 6% in Developed Markets [4] Financial Metrics - Adjusted EBITDA margin improved to 37.3%, up by 130 basis points from Q3 [4] - Adjusted net profit increased by 22%, with a net debt to EBITDA ratio of 2.0x [4] - Free cash flow before acquisitions was EUR 668.4 million, significantly higher than EUR 361.3 million in Q3 [4] Future Outlook - The company now expects organic sales growth for 2025 to be between 7-8%, previously estimated at 6-8% [4] - Excluding the impact of exiting certain countries, the organic sales growth for the year is projected at 8-9% [4] - The adjusted EBITDA margin is anticipated to be at the lower end of the 37-38% range, factoring in currency headwinds [4]